Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™.
Articles
Study: U.S. Marijuana Legalization Would Create a Million New Jobs, $132 Billion in Tax Revenue in First 8 Years - From Washington Post
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency
One area of the industry that appears to offer significant growth potential is the application of bitcoin and other cryptocurrencies to sectors of the economy, such as the cannabis industry.
Medical Cannabis Payment Solutions (REFG) to Provide Premiere, Comprehensive Digital Payment Solution
With growing trends toward legalization of medical and recreational use of marijuana, Medical Cannabis Payment Solutions (OTC: REFG) will provide a first-in-market digital payment solution for dispensaries.
Companies Offer Intriguing Investment Opportunities as Bitcoin Continues Smashing Records
Various enterprising companies emerging within the marketplace are providing promising ancillary investment options for those seeking to cash in on bitcoin’s rising star without investing directly in it.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Offers a Sweet Escape for Cannabis Users without Smoking or Sweeteners
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids.
Medical Cannabis Supplier ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Keeps Pricing Competitive
Medical cannabis products distributed by Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) in Canada are building on the organic growing environment in any given geographical climate to provide consistent quality while keeping costs down.
Harvest One Announces $15 Million Bought Short form Prospectus Offering of Convertible Debenture Units
Harvest One Cannabis Inc. (TSX VENTURE:HVST) announces that is has entered into an agreement with Mackie Research Capital Corporation (as the lead underwriter and sole bookrunner), on behalf of a syndicate of Underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis and sell to the public, 15,000 convertible debenture units of the Company at a price of $1,000 per Debenture Unit for aggregate gross proceeds of $15,000,000.
Copy of Medical Cannabis Supplier ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Keeps Pricing Competitive
Medical cannabis products distributed by Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) in Canada are building on the organic growing environment in any given geographical climate to provide consistent quality while keeping costs down.
EVIO, Inc. (EVIO) Anticipates Growth Through Imminent Regulation Change in California
Leading provider of cannabis analytical testing services EVIO, Inc. (OTCQB: EVIO) is anticipating the new testing rules for cannabis in California as a potential opportunity to profit.
Tokyo Smoke Beltline in Calgary opens December 7
First Tokyo Smoke to open outside of Ontario for the premium cannabis lifestyle brand.
PotNetwork Holding, Inc. (POTN) CEO Dr. Richard Goulding to Discuss Recent Achievements, Corporate Outlook on R.P. Summit Business Hour
Dr. Richard Goulding discussed recent achievements, corporate outlook on R.P. Summit Business Hour
Global Payout, Inc.’s (GOHE) MTRAC Subsidiary Establishes Industry Connections at MJBizCon
Global Payout (OTC: GOHE) today announced that its majority owned MoneyTrac Technology, Inc. (“MTRAC”) subsidiary successfully established a presence at the 2017 Marijuana Business Convention (“MJBizCon”) in Las Vegas, Nevada.
iAnthus Announces Closing of $12 Million Offering and $3.7 Million Non-Brokered Private Placement
iAnthus Capital Holdings, Inc., (CSE: IAN) (CSE: IAN.CN) (CNSX: IAN), announces that it closed its previously announced offering of 7,072,500 common shares of the Company at a price of $1.70 per Common Share for aggregate gross proceeds to the Company of $12,023,250..
India Globalization Capital, Inc. (NYSE: IGC) Reports Q2 2018 Financial Results
India Globalization Capital (NYSE American: IGC) today reported financial results for the second quarter ended September 30, 2017, as well as an overview of recent operational highlights.